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Abstract
Introduction: The prevalence of breast cancer, high saturated fat intake and environmental
toxicant ingestion continues to be an issue within the United States. The aim of this study was to
evaluate the association between urinary Bisphenol A (BPA) levels and dietary fat intake with
breast cancer diagnosis in U.S. women 30 years and older using data from the National Health
and Nutrition Examination Survey (NHANES).
Methods: This study examined dietary data for 200 women who participated in NHANES study
cycles between 2003-2014. Inclusion criteria were women aged 30 years or older with a
diagnosis of breast cancer, complete urinary BPA data, and complete dietary data for Healthy
Eating Index calculation and ability to normalize BPA for body mass index (BMI). The sample
population was matched with a randomly selected group of women of similar age from the same
NHANES study cycles but no diagnosis of breast cancer. Non-parametric statistical analyses
were performed. After descriptive and correlations were performed for preliminary statistics, the
study population was divided into three groups for analyses: 1) never diagnosed with breast
cancer (n=100), 2) less than 5 years since diagnosis (n=39), and 3) greater than 5 years since
diagnosis (n=61) for regression and ANOVA analyses.
Results: Out of a scale of 100, average HEI scores for each group were found to be 55.96 (13.62)
in never diagnosed, 56.58 (12.98) in women diagnosed with breast cancer less than 5 years ago,
and 58.81 (13.41) in women more than 5 years from diagnosis. In all groups, urinary BPA was
significantly correlated with HEI fatty acid ratio and saturated fat intake (r= 0.20, n=200 p= 0.
007, a=0.05; r=-0.16, n=200, p=0.03, a=0.05). Urinary BPA levels, however, did not correlate
with breast cancer diagnosis (r=0.143, n=200, p=0.157, a=0.05). There were no statistically
significant interactions between saturated fat, added sugars in the diet, a healthy diet overall (HEI
score), or urinary BPA levels and a prior diagnosis of breast cancer (p>0.05 and a=0.05 for all
dietary components and urinary BPA). Urinary BPA levels varied with time since diagnosis.
Women who had been diagnosed with cancer more than 5 years prior to the survey had
significantly lower urinary total BPA levels and lower BPA levels normalized for body mass
index (BMI) than the women who had never been diagnosed or women who had been diagnosed
within the past five years, (p<0.05, a=0.05). Women who were more than 5 years from diagnosis
also had significantly higher levels of polyunsaturated fat in their diets than women who were
never diagnosed or had been recently diagnosed. Although not statistically significant, both
groups of women with a prior cancer diagnosis scored higher on the HEI than women who had
never had a cancer diagnosis. Cancer survivors of greater than 5 years since diagnosis had higher
HEI scores compared to either groups.
Conclusions: The study found evidence that urinary BPA levels are associated with saturated fat
intake. The study also showed a trend for a reduction in BPA levels and an increase in dietary
polyunsaturated fat intake in cancer survivors more than 5 years post-diagnosis. It could be
inferred from these trends that women modify their diet and fat intake levels post-cancer
diagnosis. The study did not, however, find links between overall diet quality, saturated fat, or
urinary BPA levels and a prior cancer diagnosis. This finding is consistent with previous
research that suggests neither BPA levels in the blood nor saturated fat can be statistically linked
to the incidence of breast cancer. That does not mean endocrine disruptors have no role in the

development of cancer. Diet, lifestyle, and environmental factors all have the potential to alter
DNA methylation, gene expression patterns, and inflammatory responses resulting in adverse
health outcomes. Future examinations of the relationships between plastic packaging, canned
foods, and processed foods on urinary BPA levels and the prevalence of breast cancer should be
taken into consideration.
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1
1. Literature Review
A. Overview
Breast cancer is on the rise across the world, with a notable increase in aggressive forms
of cancer in young women (Teegarden, 2012). The American Cancer Society estimated that
approximately 40920 women would lose their lives to breast cancer in the United States during
2018, making it the second leading cause of cancer death in females (American Cancer Society,
2018). Breast cancer occurs when cells within the ductal glands or lobules continuously grow
and divide, eventually forming a tumor. The presence of malfunctioning tumor suppressor genes,
mutated proto-oncogenes, or specific genomic single nucleotide polymorphisms (SNPs) may
allow the tumor to grow and metastasize (American Cancer Society, 2018). The diversity of gene
expression profiles found in breast cancers indicates that transcriptional control may determine
the outcome of the disease. Since DNA transcription, and therefore gene expression patterns, can
be controlled and modified by diet there is a need for studies on nutrients and dietary factors that
might affect epigenetic control of transcription and cancer incidence and survivorship
(Teegarden, 2012).

Risk Factors of Breast Cancer
Hormones & Age:
Reproductive confounders such as age at menarche, age at first birth, age of last
menstrual cycle, and parity must be considered when attempting to understand the effects of
hormonal levels on cancers predominantly found in females (Bernstein et al., 1993). These
ontogenetic factors produce fluctuations in the endocrine system, particularly in estrogen
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production. Estrogens are of particular interest as these hormones and hormone fractions
influence the growth of breast epithelium (Bernstein et al., 1993).
Two principal estrogens circulate in the blood: estradiol and estrone. Estradiol is the most
active estrogen hormone in breast tissue. These estrogen levels change across the lifespan.
Females of reproductive age tend to have significantly higher levels of estradiol and estrone than
other age groups. Postmenopausal females tend to have a higher risk of breast cancer as the
ovarian production of these estrogens ceases, while their production continues as a byproduct of
the metabolism of adrenal androgens (e.g., testosterone and androstenedione). When these
androgens are produced, they are subsequently metabolized into estrogens (Bernstein et al.,
1993). Studies have shown that postmenopausal females with higher levels of these estrogens
have a significantly higher risk of breast cancer as compared to healthy postmenopausal females
in the United States (Dorgan et al., 1996; Dorgan et al., 1997; Thomas et al., 1997; Hankinson et
al., 1998; Toniolo et al., 1995).

Environmental Toxicants; Bisphenol A (BPA):
Several studies have shown that environmental toxicants, diet, and lifestyle play crucial
roles in cancer. Environmental toxicants, in particular, can disrupt physiological homeostatic
mechanisms, including those of the endocrine system. BPA is an environmental toxicant and
endocrine-disrupting hormone with a wide distribution in every-day household and
food/beverage items. When BPA or any other endocrine disruptor is ingested, absorbed and
assimilated at the adipose tissue level, they can increase or decrease normal, homeostatic
hormonal levels, mimic natural hormones within the body, or alter production of those natural
hormones (NIH Endocrine Disruptors, 2019).
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BPA is found in the manufacturing of polycarbonate plastics such as beverage containers,
plastic dinnerware, toys, and other everday household items. BPA exposure occurs when foods
or beverages are packaged in containers made from BPA-containing plastics, or oral contact or
hand-to-mouth contact with BPA-containing materials (CDC, 2017). Upon exposure, BPA
interacts with estrogen receptors found in a wide range of mammalian cells. Estrogen receptors
have a high affinity for BPA due to structural similarities with estradiol; as a result, BPA can
cause adverse endocrine changes within the body (Fig. 1; Palacios-Arreola et al., 2017). These
changes can occur within reproductive organs, mammary development, adipose tissue, the
immune system, and within a fetus during sexual differentiation, subsequently increasing risk to
hormonal cancers like breast cancer (Palacios-Arreola et al., 2017).
Numerous animal studies have identified the mechanisms of breast cancer risk due to
BPA ingestion. A 2017 study conducted by Xu et al. used both bovine vascular endothelial cells
(BVECs) and female mice to assess BPA-induced hypoxia inducible factor 1-alpha (HIF-1alpha)
and vascular endothelial growth factor (VEGF) gene expression in order to have a better
understanding of the molecular mechanism of tumor progression in vascular endothelial and
breast cancer cells of mice (Xu et al., 2017). Xu et al. (2017) suggested cellular exposure to BPA
under low-oxygen conditions, or a hypoxic environment, such as that found in breast cancer cells
or vascular endothelial cells, increases susceptibility to induction of HIF-1alpha expression. This
gene expression, in turn increases tumor cell proliferation and migration (Xu et al., 2017).
Another study conducted in 2017 sought to perform genome-wide methyl-binding
domain sequencings (MBDCap-Seq) on mammary glands of ten 100-day-old per lactating dam
of rats that were prepubertally exposed to BPA and phytoestrogen genistein (GEN) alone or
together in order to explore the epigenetic factors to breast cancer throughout life (Jadhav et al.,
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2017). The network analysis identified differentially methylated genes in human female breast
care patients compared to the rats; bioinformatic techniques were then used to evaluate genetic
predictors of long-term survival (Jadhav et al., 2017). The network analysis found that there were
4 (BPA), 119 (GEN), 134 (BPA+GEN), and 305 (control) genes with differentially methylated
loci in the rats (Jadhav et al., 2017). The top differentially connected networks related to BPA
exposure involved cellular assembly/organization, organismal injury/abnormalities, cancer, cell
death/survival, reproductive system disease, cellular movement, cell cycle, and cell morphology
similar to those genes of human breast cancer patients (Jadhav et al., 2017).
The results from this study show that postnatal exposure to BPA may result in long-term
epigenetic modifications within breast tissue; these modifications remain stable for long periods
because of the changes to the genome (Jadhav et al., 2017). There may, however, be potential to
reverse BPA’s effects on breast cancer progression through the consumption of phytoestrogen
genistein (Jadhav et al., 2017). If these findings are extrapolated to humans, the possibility that
BPA exposure may epigenetically modify genes involved in breast cancer progression should be
considered. The dietary consumption of phytoestrogenic plants, however, could potentially
reverse those epigenetic modifications.
Not only have researchers studied the effects of BPA on breast cancer in real-time, but
they have also looked at the tumor microenvironment over time and throughout adulthood in
mice (Palacios-Arreola et al., 2017). Mice share 99% of the same genes with humans. A study
conducted by Palacios-Arreola et al. (2017) proposed that endocrine disruption by BPA may
permanently alter the immune system. These changes would likely affect the anti-tumoral
response during the neonatal stage, as the endocrine system and the immune system interact with
one another (Palacios-Arreola et al., 2017).
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Through exposing female neonate mice to BPA, assessing endocrine parameters, cell
cultures, 4T1 tumor induction within the mammary tissue at the time of sexual maturity, flow
cytometry, immunofluorescence, and RT-PCR, it was found that there was a significant increase
in large tumor development with an 88% increase in tumor weight (Palacios-Arreola et al.,
2017). Regulatory T lymphocytes within the tumors of the BPA exposed mice were significantly
greater in number than that of the control mice (Palacios-Arreola et al., 2017). There was a
decrease in TNFa, INFy, and a decrease in the M2 macrophage biomarker, Fizz-1 within the
BPA treated mice (Palacios-Arreola et al., 2017). Finally, there were significant differences in
estrogen receptor alpha expression through T lymphocytes, macrophages, and natural killer cells
associated with BPA exposure as well as tumor development, supporting the researchers’
hypothesis (Palacios-Arreola et al., 2017). The results from this study suggest that environmental
exposure, such as BPA ingestion, may significantly alter the genome, affecting specific gene
expression not only involved in tumor progression but also involved in the effectiveness of the
immune system.
Further support for the link between BPA ingestion and breast cancer comes from a study
by Hussain et al. (2015) on the HOX6 gene, a homeobox-containing gene associated with
mammary gland development and often overexpressed in breast cancer patients. Hussain et al.
(2015) cultured cells from 12 adult female rats with and without BPA treatment to observe the
behavior of ER+ breast cancer cells (Hussain et al., 2015). They used RT-PCR and
immunohistochemical localizations to observe the flag-HOX6 expression. They found that
HOX6 was overexpressed in breast cancer tissues as compared to the controls, with expression
higher in ER+ breast cancer cells than in ER- cells, and that transcription was BPA
concentration-dependent manner (Hussain et al., 2015). Overall, this study showed that breast
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cancer tissues with estrogen receptors can be upregulated through the increased expression of the
HOX6 gene. When BPA is added in a dose-dependent manner, both HOX6 gene expression and
tumor progression increase (Hussain et al., 2015). The link between BPA dosage and tumor
progression highlights the importance of understanding the dosage of BPA that will increase
tumor progression through the binding of the estrogen receptors in breast cancer tissue relative to
an individual’s body weight or body fat percentage.
Although results from animal studies do not always reliably apply to human systems,
there is some justification for using animal models to test BPA exposure. There have been
several studies comparing results from in-vitro human breast cancer cell lines and animal models
that have come to similar conclusions (Fillon, 2012). There is no ethical way scientists can study
BPA exposure and its internal dose-response or routes of exposure in humans (Fillon, 2012).
Without animal studies, scientists must rely on uncontrolled post-exposure observational studies
on humans. As such, the majority of breast cancer research concerning the ingestion of
environmental toxicants has primarily focused on animal models that are genetically similar to
humans (Fillon, 2012), such as mice. There are, however, studies that bridge the link between
animal and human models at the cellular level.
A study published in 2014 looked at the antisense transcript, HOTAIR, a gene silencer,
and BPA and diethylstilbestrol (DES) exposure in both human breast cancer cells and rat
mammary tissue (Bhan et al., 2014). Cell cultures were treated with estradiol, BPA, and DES,
and RNA extraction. RT-PCR, qPCR, were used to quantify expression patterns (Bhan et al.,
2014). HOTAIR expression was induced by both BPA and DES in the human breast cancer cells
as well as the rat in-vivo model in a dose-dependent manner (Bhan et al., 2014); 100nM of BPA
and 10nM of DES caused a 6-fold increase in expression whereas 0.1nM of estradiol caused an
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increase of 5-fold. When estradiol was present with BPA and DES, however, there was a slight
reduction in HOTAIR expression (Bhan et al., 2014). Similar results were found in the in-vivo
rat model; expression was upregulated in the mammary glands (4.1-fold BPA; 3.3-fold estradiol)
(Bhan et al., 2014). These results suggest that when estrogen molecules are present along with
endocrine disruptors (e.g., BPA), there is competition for the estrogen receptors. Estrogen
receptors have a higher affinity for estradiol than BPA; its presence potentially reverses the risk
of BPA on breast cancer due to decreased binding (Bhan et al., 2014).
A study conducted by Song et al. (2017) explored the mechanism by which BPA induces
inflammatory pathways in both human pulmonary epithelial cells as well as human breast cancer
cells. The study focused on the relationship between urinary BPA levels and inflammatory
markers in elderly populations aged 60 or older (Song et al., 2017). Using in-vitro human breast
cancer cells, the researchers performed several molecular biological assays to determine COX-2
expression and found that BPA treatments induced COX-2 expression through the NF-kB
pathway and the MAPK pathway, both known inflammatory pathways (Song et al., 2017).
Inflammatory pathways are known to influence the immune system, with the primary
response being an increase in blood circulation to the point of infection or abnormalities (Nelms
et al., 2010). Increased blood flow increases the number of circulating white blood cells and
helps re-establish homeostasis (Nelms et al., 2010); it may also promote apoptosis or an increase
in helper T lymphocyte cells. This response can prolong activation of the pathways involved in
chronic inflammation (Nelms et al., 2010). This is the case in cancers like breast cancer (Nelms
et al., 2010). Chronic inflammation is a potential cause of cancers that develop through cellular
positive feedback mechanisms. Unhealthy dietary patterns (e.g., increased saturated fat intake),
obesity, diabetes, and insulin resistance often promote chronic inflammation (Nelms et al.,
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2010). One of the major inflammatory markers controlling chronic inflammation is the nuclear
factor kappa-beta (NF-kB) molecule. NF-kB inflammatory pathways can be down-regulated
through a high dietary intake of polyunsaturated fatty acids and natural antioxidants/flavonoids
and a low intake of refined grains. Alternatively, dietary components that stimulate increased
insulin release, such as high intakes of sugar, saturated fat, and trans-fat, or increased intake of
endocrine-disrupting environmental toxicants will increase inflammation (Nelms et al., 2010).
COX-2 pathways are known to play a role in inflammation, along with tumorigenesis
(Song et al., 2017). NF-kB belongs to a known family of transcription factors, complexes, and
dimers controlling the expression of several genes that are known to be involved in cellular
processes like cell proliferation/differentiation and apoptosis (Park et al., 2016). Components of
NF-kB involved in the expression of COX2 are the p50/p65 dimer and a complex of kinases
(Park et al., 2016). Figure 2 illustrates the NF-kB pathway with which increases COX2
expression. Song et al. ’s work suggested that BPA treatment induces an increase in ROS
production, potentially increasing the activation of NF-kB, hence increasing COX-2 expression
(Fig. 2; Song et al., 2017). These results suggest that BPA levels within elderly, post-menopausal
populations increase inflammatory markers as well as COX-2 expression, thus increasing overall
inflammation and inflammation and potentially causing an increase in tumorigenesis in breast
tissue (Song et al., 2017).
Evidence from both animal and in vitro human studies demonstrates a correlation
between BPA and increased risk of breast cancer. BPA also appears to promote tumorigenesis
with diet potentially modifying the risk (i.e., either increasing or decreasing tumorgenesis
depending on dietary components). Additional factors, however, such as diet and physical
activity levels, must also be considered as modifiers for the risk of breast cancer.
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Dietary Fat Intake:
Like other cancers and diseases, diet plays an important role in both the risk and
prevention of breast cancer. A 2017 multi-case-control study conducted by Castelló et al.
explored the effects that three dietary patterns, designated as Western, Prudent, and
Mediterranean, might have on breast cancer risk (Castelló et al., 2017). The Western diet was
defined as a diet with high intakes of fat, added sugars, and red, processed meats whereas a
Prudent diet was defined as a diet with high intake of low-fat foods, vegetables, fruits, whole
grains, and juices (Casetlló et al., 2017). The Mediterranean diet was defined as a diet with high
intakes of fish, vegetables, legumes, potatoes, fruits, olives, vegetable oil, a low intake of juices
(Castelló et al., 2017). This study found that the Western diet increased breast cancer risk in both
pre and post-menopausal women, whereas the Prudent diet did not show any effect on breast
cancer at all (Castelló et al., 2017).
The Mediterranean dietary pattern, however, was found to be protective against breast
cancer (Castelló et al., 2017). These findings are significant because although some individuals
and healthcare professions consider low fat intake to be healthy overall, it does not have any
beneficial effects when considering breast cancer. In contrast, a diet that is high in unsaturated
fats due to fish consumption and olive and vegetable oils (poly and monounsaturated fatty acids),
is protective. These three classes of fatty acids (saturated, monounsaturated, and
polyunsaturated) differ in molecular structure.. A monounsaturated fatty acid, such as oleic acid,
has only one double bond in its chain, allowing for different chemical properties than that of a
saturated fatty acid with no double bonds in its chain (Lada, 2003). Polyunsaturated fatty acids,
such as omega-3 and omega-6 fatty acids seen in seafood and vegetable oils, have two or more
double bonds in its structure; this allows for more fluidity than is seen in saturated fatty acids
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(Lada, 2003). Research has shown that both of these unsaturated fatty acids have beneficial
effects on both coronary-artery disease (Lada, 2003). Both mono- and polyunsaturated fatty acids
aid in reducing total LDL-cholesterol compared to saturated fatty acids (Lada, 2003). This leads
to the question of whether it is the fat intake that is the problem, or the ratio of unsaturated fat to
saturated or trans-fat intake. Fish, a common food component of the Mediterranean Diet, as well
as other kinds of seafood and plant oils, have a fatty acid ratio higher in unsaturated fats.
Researchers conducted a randomized control trial to examine the effects of the
Mediterranean diet on breast cancer through the analysis of this diet supplemented with extra
virgin olive oil or nuts in the PREDIMED trial (Toledo et al., 2015). Using 4282 women from
the PREDIMED trial from 2003-2009, the researchers randomly assigned subjects to treatment
groups in a 1:1:1 ratio (Toledo et al., 2015). These treatment groups were: Mediterranean diet
supplemented with extra virgin olive oil, Mediterranean diet supplemented with nuts, and a
control group with no supplemental foods and a decrease in overall fat intake (Toledo et al.,
2015). The researchers ran group sessions at both baseline and quarterly during the 6-year
intervention where participants completed a dietary questionnaire for the Mediterranean diet
groups and a dietary questionnaire for the control (Toledo et al., 2015).
With breast cancer as a secondary outcome and controlling for covariates including
energy intake with nutrients, smoking, sociodemographic variables, weight, height, and waist
circumference, the researchers found that after a follow up of 4.8 years, there were 35 confirmed
incident cases of breast cancer (Toledo et al., 2015). The observed rates for each group were as
follows: 1.1 for Mediterranean diet with extra virgin olive oil, 1.8 for Mediterranean diet with
nuts, and 2.9 for control, suggesting that there are potential beneficial effects of the
Mediterranean diet with extra virgin olive oil (Toledo et al., 2015). These incident rates could
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potentially be explained by the enhanced absorption of nutrients aiding in a decrease of breast
cancer risk through the aid of extra virgin olive oil whereas a Mediterranean diet supplemented
with other fats such as nuts, had no benefits (Toledo et al., 2015). Although research has already
suggested that the Mediterranean diet is beneficial for the reduction of breast cancer risks,
supplementing this diet with extra virgin olive oil enhances these effects. The results from the
Toledo et al. (2015) study suggest that the contents of the oil (monounsaturated fats, oleic acid,
polyphenols/flavenoids) have antiproliferative effects through changing the expression of
oncogenes at an epigenetic level, potentially the NF-kB inflammatory response (Toledo et al.,
2015).
The Mediterranean dietary pattern has also been shown to be beneficial in reducing
cancer recurrence and increasing cancer survival rate post-diagnosis. One prospective study was
designed to assess the relationship between post-breast cancer diagnosis dietary factors and allcause mortality in women with invasive breast cancer history (Beasley et al., 2011). The
researchers used a 126-item food frequency questionnaire (FFQ) to assess dietary intake, and
hazard ratios (HR) and confidence intervals (CI) to calculate estimated macronutrient and
micronutrient intake in relation to breast cancer diagnosis (Beasley et al., 2011). Women in the
highest quintile of saturated and trans-fat intake had a significantly higher risk of death,
suggesting that a lower intake of dietary saturated fats post-diagnosis is associated with an
improved survival rate for breast cancer patients (Beasley et al., 2011). The results from this
study suggest that dietary patterns low in saturated and trans-fat intake, post-cancer diagnosis,
have a beneficial effect on breast cancer recurrence in these individuals, making diet quality and
habits important for both reducing the risk of diagnosis as well as reducing cancer recurrence or
cancer death.
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The Healthy Eating Index (HEI):
The Healthy Eating Index (HEI) is widely used in epidemiological and intervention
research. It permits a measure of diet quality, independent of quantity, that can assess alignment
with the dietary patterns suggested by the Dietary Guidelines for Americans (Kirkpatrick et al.,
2018). As a scoring metric, the HEI reflects adequacy (dietary components to increase) and
moderation (dietary components to decrease) in food choice recommendations. Components of
the HEI are expressed and scored on a density basis in relation to energy intake (Kirkpatrick et
al., 2018). Calculation of an HEI score requires dietary data, such that is generalized by 24-hour
recall records (Kirkpatrick et al., 2018).
The current HEI-2015 scoring algorithm is based on 13 components (9 adequacy, 4
moderation; Kirkpatrick et al., 2018; Reedy et al., 2018). Adequacy components include total
fruits, whole fruits, total vegetables, greens and beans, whole grains, dairy, total protein foods,
seafood and plant proteins, and fatty acid ratio of mono and polyunsaturated fatty acids to
saturated fatty acids (Reedy et al., 2018). Although the HEI-2015 includes seafood consumption,
it does not differentiate between types of seafood (Kirkpatrick et al., 2018). The moderation
components of the HEI-2015 scoring include refined grains, sodium, added sugars, saturated fats,
and empty calories (Reedy et al., 2018).
Numerical scoring for the HEI is based on the sum of scores of each component,
including both adequacy and moderation components; the maximum total HEI score is 100, and
the minimum is zero (Kirkpatrick et al., 2018). Each of the HEI components has a maximum
score of 10 points; however, if components include subcomponents, the subcomponents have a
maximum score of 5 points (Table 1.) (Kirkpatrick et al., 2018). After the addition of each
component HEI score, the total score indicates the overall diet quality of that individual, with a
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better overall diet scoring closer to 100 and a poor overall diet scoring closer to zero (Kirkpatrick
et al., 2018; Reedy et al., 2018). Researchers can estimate amounts of particular nutrients
consumed, such as folate, from the score of leafy green vegetables.
The HEI has been used previously for a prospective cohort study that examined postcancer diagnosis mortality in post-menopausal women with breast cancer (George et al., 2014).
Participants were given food frequency questionnaires in order to determine the statistical
significance of dietary patterns according to the HEI-2005 (George et al., 2014). From this, it
was found that a better post-cancer diagnosis diet was associated with a reduction in cancer death
(George et al., 2014). The findings from this study support previous findings that diet quality
post-cancer diagnosis is extremely important when attempting to reduce breast cancer relapse.
The study also demonstrated use of the HEI for preventative measures within the healthcare
field.

Combined Effects of BPA and Dietary Fat on Breast Cancer Risk and Recurrence:
There are significant interactions between epigenetics, nutrition, and the development of
cancers (Bishop et al., 2015). The pathophysiology of all types of cancers is synergistic with risk
factors such as the environment, an individual’s lifestyle, genetic predisposition, and the
epigenome (i.e., the cellular environment above the level of the gene) (Bishop et al., 2015). The
mechanisms that control these epigenetic modifications are known to involve both dietary factors
(e.g., saturated fat intake) (Table 2.) and environmental exposures (e.g., BPA). Epigenetic
modifications can occur in utero or throughout life, making diet, lifestyle, and environment
crucial components to health (Bishop et al., 2015). The most common epigenetic modification
with respect to all cancers, including breast cancer, is the genomic methylation pattern (Bishop et
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al., 2015). Portions of DNA sequences that are subject to either hyper or hypo-methylation are
more commonly seen in the intergenic and promoter regions (Bishop et al., 2015).
Hypermethylated regions of a DNA sequence can serve as a protective barrier to the gene
expression and thus effectively silencing specific genes (Bishop et al., 2015). In breast cancer
however, these areas of the DNA sequence are hypomethylated and readily available to be
transcribed and expressed, thus promoting tumor progression (Bishop et al., 2015). High
concentrations of dietary BPA, saturated fat, as well as added sugars are thought to increase the
hypomethylation of specific genes. Thus, these factors are potential promoters of tumorgenesis.
Research has shown that a good overall diet quality includes the consumption of dark green
vegetables and high folate concentrations (Chen et al., 2014; CDC 2020). The consumption of
folate decreases cancer risk, including breast cancer, because it plays a role in hypermethylating
the same regions of DNA that promote tumorgenesis (Chen et al., 2014; CDC, 2020).
The European Prospective Investigation into Cancer and Nutrition (EPIC) was a
prospective cohort study to determine the relationship between dietary folate/folic acid and
breast cancer risk (Batlle et al., 2015). The study found a significant inverse association between
dietary folate and breast cancer (p =0.037) in a cohort of 11575 women within postmenopausal
range (35 to 70 years) diagnosed with breast cancer (Battle et al., 2015). The conclusion was that
dietary folate decreased breast cancer risk through the hypermethylation of DNA.
The current study is specifically focused on the presence of BPA and saturated fat intake
in the diets of breast cancer survivors. It is common for diets in the United States (western diet)
to contain high levels of processed and fast foods (e.g., fast-foot hamburgers and soda) and
therefore have a lower HEI-2015 score. These foods typically contain high levels of BPA from
exposure to packaging, as well as containing a high saturated fat content (Almeida et al. 2018,
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Castello & NIH, 2018). High intakes of BPA (a fat soluble molecule) and saturated fat are
associated with altered fat metabolism and an increase in adipose tissue; subsequently increasing
the storage of BPA in the adipose tissue (Do et al., 2017). In women, this gain in adipose tissue
often occurs within the mammary tissue, predisposing them to an increase in the genomic
mechanisms leading to tumor progression.
Even if individuals attempt to consume healthier fats and less processed foods (e.g., the
Mediterranean Diet), there is still a likelihood of ingesting BPA due to bioaccumulation through
the food chain, specifically in marine foods. High concentrations of healthy fats, such as omega3 polyunsaturated fatty acids, are associated with a decrease in breast cancer risk. Unfortunately,
recent research has shown that there are also high concentrations of BPA within these foods due
to pollution from plastics (Bishop et al. 2015, Environmental Health Perspectives 2015). Canned
fish, such as tuna, have been shown to contain particularly high levels of BPA (e.g., 106 ng/g;
Almeida et al., 2018). Trace quantities of BPA have been found in all bodies of water across the
globe (Environmental Health Perspectives, 2015). BPA contamination potentially increases in
severity from the high rate of pollution from environmental micro-plastics. Micro-plastics are
absorbed and metabolized by sea life, undergoing increasing concentration up through the food
chain. Eventually, the accumulated micro-plastic concentration ends up in the human diet
through the consumption of fish and other kinds of seafood (Zhou et al., 2018; Environmental
Health Perspectives, 2015).

Socioeconomic and Related Risk Factors:
Many cancers are diagnosed more often in one particular race or ethnicity than others.
Breast cancer conforms to this pattern. The CDC states that as of 2016, per 100,000 women

16
worldwide, breast cancer was more commonly found in white and black women than other
demographics (CDC, 2020). This difference between groups is due to differences in genetics,
environmental exposures due to the locations in which these particular demographics are
predominantly found, and other factors that lead to increase risk in this cancer (CDC, 2020).
Studies have shown that BPA is present in measurable concentrations in the tap water of
several different areas in the United States. Although tap water tends to have a lower in BPA
concentration than that of fish and seafood, it is important to include tap water consumption as a
potential confounding variable in the analysis of associations between BPA and cancer (Arnold
et al., 2013).
Alcohol consumption is also a well-known risk factor for many cancers. Several studies
have shown that the more alcohol consumed, the higher the risk of breast cancer (CDC, 2020).
This is due to 1) alcohol’s interface in folate absorption across the intestinal enterocytes and 2)
renal conservation of folate in the individual consuming the alcohol (Wani et al., 2013). Alcohol
ingestion also appears to counteract the effect of folate on DNA methylation patterns. Alcohol
causes hypomethylation patterns allowing for tumor expression genes to be transcribed,
increasing tumorgenesis in the breast tissue (Wani et al., 2013).
Finally, education level also plays a part in increasing or decreasing the risk of disease.
Research has shown that there is a direct dose-response association between women’s education
level and post-menopausal breast cancer risk (Heck, 1997). Similar to education level, family
income poverty ratio may also affect breast cancer risk and recurrence. The reason for this not
only stems from reduced access to breast cancer education but also reduced availability to make
doctors visits or take rehabilitative action in decreasing risk or recurrence (Schootman et al.,
2008).
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Using NHANES Data to Examine the Relationships between BPA, HEI, Dietary Fat, and Breast
Cancer Survivorship:
Prior analysis of HEI scores derived from NHANES data has shown that in general, postcancer diagnosis diets higher in saturated fat and low in unsaturated fat are associated with
increased cancer mortality (Deskmukh et al., 2018). An independent analysis of HEI scores
showed an inverse relationship with the risk of breast cancer death, specifically (George et al.,
2014). The current study seeks to elaborate on earlier studies by including a BPA biomarker in
the analysis. This study used data from postmenopausal women from the years of 2003-2014,
who have had a previous diagnosis of cancer to explore links between the HEI scores, current
levels of inflammatory biomarkers, and levels of urinary BPA excretion. We compared these
trends to dietary patterns and urinary BPA levels found in age-matched women who have never
had a diagnosis of cancer. We expected to see significant differences in HEI scores between
cancer survivors and women who have never had a cancer diagnosis. We also predicted that
cancer survivorship, as estimated by time elapsed following a cancer diagnosis, will correlate
with higher HEI scores and lower levels of BPA excretion and inflammatory biomarkers. Our
analysis used data from the National Health and Nutrition Examination Survey (NHANES).

2. Manuscript
A. Introduction
Previous research has shown that some dietary patterns increase the risk of breast cancer
whereas others, such s dietary patterns similar to the Mediterranean Diet, tend to decrease cancer
risk. Specifically, high dietary saturated fat intake has been shown to have a significant increase
to the risk of death both before and following breast cancer diagnosis and increase the risk to the
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onset of breast cancer and cancer recurrence (Beasley et al. 2011, Jochems et al. 2018). The aim
of this study was to use NHANES data from survey cycles between 2003-2014 to examine
associations between urinary BPA levels, saturated fat intake, and dietary quality in women with
either a diagnosis of breast cancer or women with a post-cancer diagnosis. The study population
included women in the United States who have never been diagnosed with breast cancer, those
diagnosed less than five years since the completion of the NHANES survey, and those diagnosed
more than five years from the completion of the NHANES survey.

B. METHODS

Study Design and Participants
The NHANES survey program is a widely used program for the National Center for
Health Statistics (NCHS), which is a part of the CDC and provides health statistics for the U.S.
(NCHS, 2018). NHANES data permit a measure of both the exposure to dietary factors and a
given biomarker outcome at one point in time, showing a potential correlation. Using the
interview and examination components of this survey, health professionals can study a
representative sample of the U.S. (NCHS, 2018). Each year, a sample of about 5000 participants
in counties across the country are used for this survey (NCHS, 2018). The interview component
of this survey includes questions regarding demographics, socioeconomic status, dietary habits,
and health-related issues whereas the examination component includes laboratory tests, medical,
dental, and physiological measurements conducted by medical professionals (NCHS, 2018).
Dietary and biomarker data from the United States NHANES data cycles between 20032014 were used to test two hypotheses: 1) that current urinary BPA levels and a past breast
cancer diagnosis are correlated, and 2) that dietary patterns (e.g., higher polyunsaturated &
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monounsaturated fat intake, higher HEI score) and breast cancer survivorship are correlated. The
study is retrospective in design, although the data were cross-sectional. The NHANES 20032014 cycles were explicitly chosen because they include all variables required for testing the
proposed hypotheses and can be scored using the HEI. The dependent/outcome variable for both
hypotheses were breast cancer diagnosis and the independent/exposure variables included
urinary BPA, dietary fat intake, and HEI scores.

Subjects Selection and Inclusion Criteria:
Screening of 10 years of available NHANES data resulted in the identification of 100
cases of breast cancer in women over the age of 30 years old. The survey asked when breast
cancer was diagnosed in terms of the age of the individual. Because of the way in which the
survey question was formatted, several of these cases had a breast cancer diagnosis of a missing
value (.) (NHANES, 2019). For this study, those cases were classified as a component of the
control/never diagnosed with breast cancer study group. Using the total pool of women over 30
who had never been diagnosed with breast cancer, including those with a missing value, between
2003 and 2014, a subsample of 100 control cases were selected using a random number
generator (https://www.randomizer.org). These groups were used for initial comparisons
between women diagnosed with cancer and those never diagnosed (the control group) and to
identify confounding variables through correlation analysis. Additional analyses examined
dietary differences between women diagnosed less than five years before the time of the survey
(n=39) and more than five years prior to the survey (n=61).

Measures
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Breast Cancer Diagnosis:
The CDC collected breast cancer diagnosis through the NHANES survey from 2003 to
2014 and reported this as a variable label code MCQ240E, within the medical conditions section
(CDC, 2018). This section provides self-reported personal data that was provided through an
interview process including a broad range of medical conditions (CDC, 2018). Breast cancer
diagnosis was given at the age in which the individual was first diagnosed (CDC, 2018),
allowing for more straightforward data collection for the use of individuals aged 30 years or
older. The data were recorded under codes with value descriptions along with the number of
participants who answered with specific responses.

Urinary BPA Levels:
Urinary BPA levels (URXBPH) were reported in ng/mL in the NHANES database
(CDC, 2018). Urinary levels of any substance are usually indicative of spillover, meaning the
individual has consumed large quantities of this substance so the body excretes the excess. Thus,
having large quantities of BPA within the urine would be indicative of excessive quantities of
BPA within the body.
The CDC uses urinary levels of environmental toxicants to determine its occurrence in
humans (CDC, 2018). BPA levels within the urine are measured by using biological matrixes
within gas chromatography or high-performance liquid chromatography (CDC, 2018). Urine
samples were processed, stored, and shipped to the Division of Environmental Health Laboratory
Sciences, National Center for Environmental Health, Centers for Disease Control and Prevention
(CDC) to ensure high-quality. At the center, the samples were stored at -20 degrees Celsius
(CDC).
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Dietary Assessment:
Values for average energy intake, saturated fat intake, and polyunsaturated fat intake
were determined for each subject from two day-dietary recalls; these then became the basis for
the HEI calculation. The USDA’s MyPyramid Equivalents Database for USDA survey foods
allows researchers to locate foods and food groups that are in equal amounts and patterns to
determine diet quality through the HEI scores (USDA, 2017, National Cancer Institute HEI,
2015). The HEI accounts for the following food groups: total vegetables, green beans, total fruit,
whole fruit, whole grains, dairy, total protein foods, seafood and plant proteins, the ratio of fatty
acids (saturated and poly/mono unsaturated), sodium, refined grains, saturated fats, added sugars
(NIH, 2019). These are then expressed as numbers of cups, ounces, teaspoons, and/or grams
following the interview component of the dietary recall within the NHANES survey (Table 1.).
Data files of the HEI individual food groups and nutrients for each subsequent year of
NHANES were downloaded using the SAS/STAT® version 9.4 software program. SAS codes
were used to calculate HEI-205 scores (NIH, NCI, 2019) for each individual. The main food
groups of focus for this study were seafood and plant proteins, fatty acids, saturated fats, and
alcohol. Seafood and plant proteins were chosen as a focus due to similarity to the large quantity
of poly and monounsaturated fats found in a Mediterranean diet. However, it was also of focus
due to the potential for increased BPA contamination from bioaccumulation and pollution (Zhou
et al. 2018, Environmental Health Perspectives, 2015). The fatty acid component of the HEI2015 was of relevance and interest because it allowed for a better understanding of how the fatty
acid ratio between saturated and unsaturated fats, affects breast cancer and BPA levels (National
Cancer Institute HEI, 2015). The HEI-2015 score was matched to the sequence number assigned
to the subject through NHANES to further statistical analysis (SAS, 2016).
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Statistical Analysis:
Descriptive statistics of demographic variables were used to determine frequencies and
averages for each study group. All variables were tested for normality before further analysis.
Data that were not normally distributed according to the Kolmogorov-Smirnov test of normality
were log-transformed as appropriate or were analyzed using non-parametric analyses. This
included measurements of urinary BPA for both the control group, D(100) = 0.324, p = 0.00 and
those diagnosed with breast cancer D(100) = 0.408, p = 0.00. Correlation matrixes generated
through SPSS were used to determine pairs of variables with the highest correlations within the
study (IBM Corp. Released 2016. IBM SPSS Statistics for Windows, Version 24.0 Armonk, NY:
IBM Corp.). Logistic and multiple linear regression models, ANOVA, and ANCOVA were used
to examine the association of breast cancer diagnosis as a function of urinary BPA levels, dietary
components, total HEI scores, and HEI dietary components within three diagnosis groups of
never diagnosed, diagnosed less than five years since survey, and diagnosed more than five years
since the survey.
Urinary BPA levels were normalized by each subject’s BMI to account for body size/fat.
Research has shown that adipose tissue has a high affinity for BPA hence, high storage capacity
(NIH Endocrine Disruptors, 2019). In conjunction with this, the presence of BPA in the urine is
indicative of BPA spillover when adipose storage, including mammary tissue, has reached its
limit (NIH Endocrine Disruptors, 2019). Normalizing BPA levels with respect to BMI accounts
for the fact that BPA levels are likely higher in people with more body fat, thereby removing the
effect of body size as a variable. Although BPA normalized by adiposity would have been more
appropriate for this analysis, the NHANES data do not include information on body composition;
BMI was therefore used as a surrogate measure for adiposity.
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Potential confounding variables were identified from a review of the literature, including
race/ethnicity (Mexican American, Other Hispanic, non-Hispanic white, non-Hispanic black),
educational level (<9th grade, 9-11, high school/GED, bachelors/associates, > college), family
income poverty ratio, BMI (continuous in kg/m2), fish consumption, tap water consumption,
alcohol use, refined grains, and added sugars. Several of these variables were excluded from the
final analysis after verifying that no significant interaction or correlation existed.

C. RESULTS
Demographics:
Women over the age of 30 who had never been diagnosed with breast cancer (n=100) were
used as a control group to be compoared to women over the age of 30 who had been diagnosed
with breast cancer (n=100). To examine the effects of dietary BPA on post-cancer diagnosis
survivorship, breast cancer survivors were further divided into two groups: one of less than five
years since diagnosis (n=39) and one of more than five years since diagnosis (n=61).
The mean (±SD) age in years for each analysis groupings was 54 (15) for the control group,
65 (11) <5 years post-diagnosis, and 70 (11) >5 years post-diagnosis. The dominant race for all
groups was non-Hispanic White (55%). The highest education level completed for each group
was high school diploma (26%) for the control group, high school diploma and associates degree
(33.3%, 33.3%) for <5 years post-diagnosis, and associates degree for >5 years post-diagnosis
(24.7%). For the study group including subjects with less than five years since diagnosis, the
average (±SD) number of years since diagnosis was 3 (1.52). The average number of years since
diagnosis for subjects greater than five years since diagnosis was found to be 14 (7.48) years
(Tables 3, 4, and 5.). Average BMI for the control group was found to be 31 (8.40). The average
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BMI for <5 years post-diagnosis was found to be 30 (6.0) whereas it was 28.8 (5.90) for the >5
years post-diagnosis group.

Correlations:
All variables were initially tested for potential correlations using Pearson’s rho. Many of
the potential confounding demographic variables had no significant relationship with urinary
BPA levels or breast cancer diagnosis. The exception was BMI, which was negatively correlated
with age at which breast cancer was first diagnosed (r = -0.27, p = 0.01); therefore, as the
number of years since diagnosis increased, BMI tended to decrease. Insignificant variables were
excluded from further analysis, including those of race/ethnicity, education level, family income
poverty ratio, fish and tap water consumption, and alcohol use.
Several components of the HEI-2015 were significantly and positively correlated with one
another (Table 6). The HEI fatty acid ratios of saturated to unsaturated, and saturated fat intake
of the subjects were positively correlated with urinary BPA (r = 0.20, p = 0.01; r = -0.16, p =
0.03 respectively) (Table 6.). Added sugars were not significantly correlated with urinary BPA (
r = 0.05, p= 0.52), but were significantly correlated with saturated fat intake (p < 0.05) (Table
6.).

Can Breast Cancer Presence/Absence be Predicted from HEI-2015 Components and Urinary
BPA:
Logistic regression analysis was used to test whether cancer presence or absence could be
predicted from dietary components of fatty acid ratios, refined grains, percent calories of added
sugars, and the presence of urinary BPA based on the correlations matrix results and background
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research. The full model containing all predictors was not statistically significant, X2 (4, N=179)
= 0.32, p<0.05. Cancer presence/absence could not be predicted from these factors; the model
only explained 2% of the variance observed in breast cancer presence/absence along with no
significant odds ratios (Table 8.).

Are There Differences In Urinary BPA/BMI, PUFAs, and HEI-2015 Among the Three Study
Groups:
One-way ANOVA’s and post-hoc means separation tests were used to detect differences
in urinary BPA normalized by BMI levels (BPA/BMI), PUFAs, and HEI-2015 among the three
diagnostic groups. Mean BPA/BMI levels were 3.69 (7.77) ng/ml in the never diagnosed group,
4.95 (13.77) ng/ml in women diagnosed with breast cancer less than 5 years ago, and 3.44
(10.152) ng/ml in women more than 5 years from diagnosis. Mean dietary PUFA levels were
16.24 (8.95) g in the never diagnosed group, 14.01 (8.45) g in women diagnosed with breast
cancer less than 5 years ago, and 13.98 (9.23) ng/ml in women more than 5 years from diagnosis.
Out of a scale of 100, average HEI scores for each group were found to be 55.96 (13.62) in never
diagnosed, 56.58 (12.98) in women diagnosed with breast cancer less than 5 years ago, and 58.81
(13.41) in women more than 5 years from diagnosis.
There were no statistically significant differences between the less than five years since
diagnosis groups and the control group for any variable (BPA/BMI F(2,94)=2.78, p=0.06; PUFA
F(2,96)=2.937, p=0.058; and HEI-2015 F(2,197)=1.881, p=0.155). Urinary BPA/BMI and
PUFAs differed between the more than five years since diagnosis group and the control group
(post-hoc LSD, p = 0.02 and p = 0.02, respectively; Table 9A-10B.). HEI-2015 scores among the
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three groups within the greater than five years since diagnosis were not statistically significant
(p= 0.06; Table 9C).

D. DISCUSSION
BMI, Saturated Fat Intake, and Breast Cancer Survival:
Researchers have found that the amount of fat consumed and type of fat consumed postcancer diagnosis influences cancer recurrence and survivorship (Jochems et al., 2018; Toledo et
al., 2015, Castello et al., 2017); this could explain the trends observed in the current study.
Subjects who survived more than five years after initial cancer diagnosis tended to have a lower
BMI than those with a more recent cancer diagnosis (less than 5 years). Women who were more
than five years past the point of diagnosis also had significantly lower saturated fat intake and
compared to the control group or those with a more recent diagnosis. The observation that BMI
and dietary saturated fat decrease with time from initial cancer diagnosis conforms to a pattern of
healthier lifestyle choices, in keeping with research that has shown that a healthier quality of life
can decrease breast cancer occurrence and recurrence (Karimi et al., 2014).
Fatty Acid Ratio, Urinary BPA, Inflammatory Response, & Breast Cancer Survival:
Xu et al. (2010) used methods similar to this study to analyze NHANES survey cycles
from 1999-2004 for associations between serum concentrations of organochloride pesticides.
Organochloride pesticide exposure may have a significant effect on cancer risk as they function
as endocrine disruptors (Xu et al., 2010) in a manner similar to BPA. We had, therefore,
anticipated results similar to that of Xu et al. (2010). Our study, however, was inconclusive. This
is not without precedent. In 2009, Yang et al. found borderline significant associations between
BPA and breast cancer risk. The sample size of that study, however, was too small (N=167) to
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detect a significant relationship (Yang et al., 2009). Yang et al. ’s (2009) findings highlight the
necessity of obtaining a sufficiently large sample size for adequate statistical power. Although
the current study analyzed data that cover a 10 year period, we were only able to identify 100
breast cancer survivors of an appropriate age to meet the analysis criteria. Our results are very
similar to Yang’s 2009 work, suggesting that small sample size likely contributed to many of the
borderline significant observations we report here.
The current study normalized BPA levels by BMI to further explore the data set and
account for adiposity. This uncovered subtle statistical significant differences amongst the three
diagnostic groups, with breast cancer survivors of more than five years showing slightly lower
urinary BPA levels. The normalization of urinary BPA levels by BMI is supported by prior
research on the environmental toxicant and its effects on BMI and obesity (Wang et al., 2012,
CDC, NIH). Normalization by body mass or composition accounts for the fact that BPA levels
are likely to be higher in people with more body fat; thus removing a confounding variable in the
analysis. The fact that the group diagnosed with breast cancer more than five years prior had
lower urinary BPA levels seems to align with prior research showing dietary modifications
reduce cancer relapse, potentially through diet-induced epigenetic mechanisms (Jahhav et al.,
207; Song et al., 2017; Beasley et al., 2011; Bishop et al., 2015). Individuals who have been
diagnosed with cancer appeared to conform to healthier dietary patterns, possibly in the hope of
decreasing the chances of cancer recurrence. In contrast, individuals who have never been
diagnosed with cancer tended to have higher normalized urinary BPA levels. The lower HEI
scores and higher BPA levels suggest that in the absence of cancer diagnosis, these individuals
had less motivation to alter their dietary habits.
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Despite the small sample size of our study, we were still able to detect a significant
positive correlation between the ratio of saturated to unsaturated fats and urinary BPA. The HEI
saturated fat component score showed an inverse relationship with urinary BPA. This component
score is on an inverse scale, with a lower score reflecting a higher consumption of saturated fat.
Thus, it supports the conclusion that increased saturated fat in the diet correlates with increases
in urinary BPA excretion. This is a potentially meaningful result in that prior research using
animal models has shown links between high-fat diets, BPA exposure and risk of cancer (Facina
et al., 2017).
High-fat diets and BPA are both risk factors for breast cancer (Zota et al. 2016, Toledo et al.
2015). Both factors operate by altering homeostatic mechanisms at a genomic level, potentially
in utero, creating a genetic blueprint for a child’s adult life. However, it is also possible that these
altered homeostatic mechanisms could be synergistic with each other, potentially enhancing their
individual activity levels. For example, a 2017 study sought to determine whether maternal
exposure to BPA and a high-fat diet intake during pregnancy can further influence breast cancer
risk in the offspring of female rats (Leung et al., 2017). DNA methylation and gene expression of
several genes, one being in the same gene family as the previously mentioned ALDH1A3
(ALDH1B1) gene, has been shown to enhance tumor survival in mice with breast cancer more
than BPA or fat alone (Leung et al., 2017).
Similar genomic mechanisms could also explain the way in which dietary saturated fat
increases estrogen production in older women, leading to an increase in adipocyte formation and
an increased number of estrogen receptors (Nagata et al., 2005). Free-floating BPA in the system
would then have a higher likelihood of binding to the increased number of receptors due to
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structural similarities with estrogen, thus contributing to increased breast cancer risk in post- or
perimenopausal females.
Although saturated fat intake was significantly correlated with an increase in urinary
BPA in this study, individual linear regressions showed no significant result within the three
study groups. When added sugars, a common synergist for cancer diagnosis, were added to the
multiple regression model, the model moved to borderline significance; this suggests that fatty
acid ratios are only one component of the relationship between BPA and breast cancer. There is
some precedent for this result; prior research suggests that BPA and added dietary sugars interact
with one another to cause regulatory problems at a molecular, cellular, and inflammatory level,
potentially leading to cancers (Branco et al., 2014). These interactions may be part of a complex
interaction between added sugars, BPA, saturated fats, and other unhealthy dietary factors that
give rise to breast cancer through an increased risk of chronic inflammation through the NF-kB
pathway. Inflammation can be linked to the hypomethylation of DNA regions that control the
increase in transcription and expression of tumor progressive genes (Nelms et al., 2010). The
overall increase in the PUFAs and HEI score seen in the greater than five years from diagnosis
group potentially increased the concentration of dietary micronutrients such as folate. The
increase in micronutrients might inhibit the NF-kB inflammatory response and aid in the
hypermethylation of specific regions of DNA (Nelms et al., 2010).
High BPA concentrations are also often associated with high levels of salt and added
sugar in the diet (Almeida et al., 2018). This can also be due to the high salt and sugar content in
processed foods, which would increase exposure to BPA contamination through processing and
packaging. The current analysis would, therefore, have been stronger if the proportion of the diet
obtained from canned, bottled, and processed foods had been considered as opposed to just the
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macro and micronutrient ratios. For example, a 2016 study conducted with NHANES data found
a positive correlation between fast food and processed food intakes and urinary BPA levels (Zota
et al., 2016).
If the current study had also considered sources of foods in the diet, such as the amount
of macronutrients consumed from canned foods and bottled drinks, it might have revealed
additional relationships through regression analysis. Because BPA is one of the most common
industrial chemicals used in canned linings, bottles, and even conveyor belts used to process and
package foods, we assume that the levels would be substantially higher in individuals who
consume a significant quantity of these foods. A 2016 study supports this supposition.
Tzatzarakis et al. (2016) used liquid chromatography-mass spectrometry to quantify the BPA in
canned food and bottled soft drinks. Mean BPA levels in the canned foods and soft drinks were
33.4 ± 4.4 ng/g and 2.30 ± 0.18 ng/ml, respectively (Tzatzarakis et al., 2016). If we had been
able to identify foods consumed from canned and bottled foods, we may have observed stronger
and more statistically significant relationships in this study.
Other factors that may have limited the results of this analysis include the relatively small
sample population and the way that the CDC collected dietary intake for the NHANES survey.
Quantitative dietary intake measurements such as food-frequency questionnaires can return
imprecise measurements, which is problematic when trying looking for relationships between fat
intake and cancer prevalence (Bingham et al., 2003).
Although the results presented here are inconclusive, previous studies suggest that
registered dietitians working with or making dietary recommendations for cancer patients and/or
patients in remission should still consider the effects of dietary BPA. The presence of BPA in
conjunction with a high-fat diet seems to amplify the pathophysiological mechanisms of cancer.
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A decrease in the consumption of canned/bottled foods potentially containing BPA should,
therefore, be recommended to reduce the risk of breast cancer. In addition, a decrease in
saturated fat intake and an increase in polyunsaturated fat intake may be helpful in decreasing
cancer occurrence in breast cancer patients. In conclusion, a diet more similar to the
Mediterranean diet should be considered to extend post-cancer diagnosis survivorship and reduce
cancer risk, including increased consumption of more whole, fresh foods and vegetables, oils,
and fish (Beasley et al., 2011).

Future Directions:
The results from this study highlight the importance of specific dietary components in
reducing the risk of breast cancer. This work could be expanded by looking at whether increased
polyunsaturated fatty acid intake can suppress the effect of ingested BPA. Clarifying that
interaction might provide a better understanding of one of the epigenetic mechanisms behind
breast cancer. Also, adding the proportion of diet obtained from canned, bottled, processed
foods, fast foods and different methodologies to measure fat intake and BPA levels could
significantly aid in a better understanding of this topic (Zota et al., 2016). Rather than
normalizing BPA with BMI, a better measurement would be to account for each subject’s fat
mass versus lean mass. This would allow for a more accurate analysis of the amount of adipose
tissue within the body, potentially correlating with increased BPA assimilation by adipose
linked estrogen receptors. Finally, a better statistical analysis of added sugars in the diet would
allow for a greater understanding of how the insulin and inflammatory response increases
specific inflammatory pathways leading to the expression of genes that increase tumor
progression.
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Strengths and Limitations:
Although there were limited statistically significant results in this study, it was still
beneficial for determining indicators of BPA in the human diet. Use of the NHANES database
allowed for access to ample amounts of data obtained through a rigorous and validated survey.
The study, however, would have benefitted from the inclusion of more dietary components from
prepackaged convenience, fast foods, and types of seafood.
Other limitations to this study include the study design and its time constraint. Although
this was a cross-sectional study, it was analyzed as a retrospective study for statistical purposes.
Using secondary data that were not collected for the specific study aims was a limitation. If it
were possible to obtain a larger sample size, greater than 200 subjects in total, there might have
been greater statistical significance, specifically in the comparison of HEI scores between the
control and two diagnosis groups. Lastly, this study design forced the assumption of previous
exposures to good/bad diet and BPA in all subjects.

E. CONCLUSIONS
This study found evidence that urinary BPA levels are associated with saturated fat
intake. The study also showed a trend for lower BPA levels and higher dietary polyunsaturated
fat intake in cancer survivors more than 5 years post-cancer diagnosis. It could be inferred from
these trends that women modify their diet and fat intake levels post-cancer diagnosis. The study
did not, however, find links between overall diet quality, saturated fat, or urinary BPA levels and
a prior cancer diagnosis. That does not mean endocrine disruptors have no role in the
development of cancer. Diet, lifestyle, and environmental factors all have potential to alter DNA
methylation and gene expression patterns, resulting in negative health outcomes. The next step in
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this research should be an examination into the relationships between plastic packaging, canned
foods, and processed foods on urinary BPA levels and the prevalence of breast cancer.
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3. Illustrative Materials
Tables:
Table 1. HEI-205 Component & Scoring Standards (Table adapted from the USDA HEI2015 Scoring Standard, 2020).
Component
Adequacy:

Maximum Points

Total Fruits1

Standard for Maximum Score

Standard for Minimum Score of Zero

5

≥0.8 cup equivalent per 1,000 kcal

No Fruit

5

≥0.4 cup equivalent per 1,000 kcal

No Whole Fruit

Total Vegetables

5

≥1.1 cup equivalent per 1,000 kcal

No Vegetables

Greens and Beans3

5

≥0.2 cup equivalent per 1,000 kcal

No Dark-Green Vegetables or Legumes

Whole Grains

10

≥1.5 ounce equivalent per 1,000 kcal

No Whole Grains

Dairy

10

≥1.3 cup equivalent per 1,000 kcal

No Dairy

Total Protein Foods3

5

≥2.5 ounce equivalent per 1,000 kcal

No Protein Foods

Seafood and Plant

5

≥0.8 ounce equivalent per 1,000 kcal

No Seafood or Plant Proteins

10

(PUFAs + MUFAs) / SFAs ≥2.5

(PUFAs + MUFAs) / SFAs ≤1.2

Refined Grains

10

≤1.8 ounce equivalent per 1,000 kcal

≥4.3 ounce equivalent per 1,000 kcal

Sodium

10

≤1.1 grams per 1,000 kcal

≥2.0 grams per 1,000 kcal

Added Sugars

10

≤6.5% of energy

≥26% of energy

Saturated Fats

10

≤8% of energy

≥16% of energy

2

Whole Fruits

3

4

3,5

Proteins

Fatty Acids6
Moderation:

1

Includes 100% fruit juices.
Includes all forms EXCEPT juices.
3
Includes legumes (beans and peas)
4
Includes milk products, such as fluid milk, yogurt, cheese, and fortified soy beverages
5
Includes seafood; nuts, seeds, soy products (other than beverages), and legumes (beans and peas).
6
Ratio of poly- and mono-unsaturated fatty acids (PUFAs and MUFAs) to saturated fatty acids (SFAs).
2
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Table 2. Epigenetic & Anti-Breast Cancer Effects of Nutrients (Table adapted from Bishop
et al., 2015)
Nutrient/Food

Source

Epigenetic Effect

Component
Omega 3-EPA & DHA

Anti-Breast Cancer
Effect

Fish Oil

Methylation of COX2 in

Fish oil increases

breast cancer cell lines

apoptosis during tumor

linked to gene silencing;

initiation acting through

maternal intake of

COX2 pathway; lower

polyunsaturated fatty

levels of COX2

acids influences
epigenetic regulation of
FADS in offspring
Trans Fat/Saturated Fat

Processed foods

DNA hypomethylation in

Associated with risk of

brains of offspring;

invasive breast cancer

histone modifications;
hypomethylation at SacII
in ER gene
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Table 3. Demographics of the Never Diagnosed with Breast Cancer Group
Demographic

N (%)

Age:
30-39

20 (20)

40-49

19 (19)

50-59

22 (22)

60-69

23 (23)

70-79

11 (11)

>80

5 (5)

Mexican American

12 (12)

Other Hispanic

5 (5)

Non-Hispanic White

55 (55)

Non-Hispanic Black

23 (23)

Other (Including Multi-Racial)

5 (5)

Race/Ethnicity:

Education:
Less Than 9th Grade
th

8 (8)

9-11 /No Diploma

16 (16)

High School/GED

26 (26)

Associated

25 (25)

Bachelor’s & Above

25 (25)
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Table 4. Demographics of the Less Than Five Years Since Diagnosis Breast Cancer Group
Demographic

N (%)

Age:
30-39

0 (0)

40-49

5 (13)

50-59

6 (15)

60-69

13 (33)

70-79

10 (26)

>80

5 (13)

Mexican American

7 (18)

Other Hispanic

1 (3)

Non-Hispanic White

21 (54)

Non-Hispanic Black

9 (23)

Other (Including Multi-Racial)

1 (3)

Race/Ethnicity:

Education:
Less Than 9th Grade
th

3 (7)

9-11 /No Diploma

3 (7)

High School/GED

13 (33)

Associated

13 (33)

Bachelor’s & Above

7 (18)
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Table 5. Demographics of the Greater Than Five Years Since Diagnosis Group
Demographic

N (%)

Age:
30-39

0 (0)

40-49

1 (2)

50-59

9 (15)

60-69

19 (31)

70-79

16 (26)

>80

16 (26)

Mexican American

3 (5)

Other Hispanic

6 (10)

Non-Hispanic White

41 (67)

Non-Hispanic Black

9 (15)

Other (Including Multi-Racial)

2 (3)

Race/Ethnicity:

Education:
Less Than 9th Grade
th

11 (18)

9-11 /No Diploma

11 (18)

High School/GED

12 (20)

Associated

15 (25)

Bachelor’s & Above

12 (20)
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Table 6. Correlations matrix for urinary BPA & HEI Scores. Significant values in bold;
n=200
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Table 7. Multiple Linear Regression to test whether urinary BPA and components from the
HEI-2015 fatty acid ratio explain breast cancer prevalence in non-white and white women.
Sum of

df

Mean Square

F

p-value

3.7

4

0.92

1.18

0.33

0.43

4

0.11

0.23

0.98

Squares
Non-White
Women
Non-Hispanic
White Women

Table 8. Logistic regression to test whether breast cancer presence/absence could be
predicted from dietary components of fatty acid ratios, refined grains, percent calories
from added sugars and the presence of urinary BPA (N=179).
B

S.E.

Wald

df

p-value

Fatty Acid Ratios

-0.02

0.27

0.01

1

0.94

Refined Grains

0.06

0.12

0.28

1

0.59

% Calories Sugars

0.00

0.02

0.04

1

0.84

Urinary BPA

0.00

0.02

0.00

1

0.97

X2

0.32
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Table 9. One-way ANOVA with LSD method of means separation to determine the
differences among the study groups (never diagnosed/control, <5 years, and >5 years).
9A. ANOVA & LSD Urinary BPA normalized by BMI (BPA/BMI)
ANOVA
BPA/BMI
Sum of
Squares
Between Groups

df

Mean Square

.606

2

.303

Within Groups

10.231

94

.109

Total

10.837

96

Mean Difference

F

Sig.

2.786

Std. Error

.067

p-value

95% Confidence
Interval (CI)

<5 Years

0.04

0.82

0.60

-0.12 to 0.21

>5 Years

0.18

0.82

0.02*

0.02 to 0.34

9B. Polyunsaturated Fatty Acids (PUFAs)
ANOVA
PUFA
Sum of
Squares
Between Groups

df

Mean Square

468.141

2

234.071

Within Groups

7650.606

96

79.694

Total

8118.747

98

Mean Difference

Std. Error

F

Sig.

2.937

p-value

.058

95% Confidence
Interval (CI)

<5 Years

-4.0

2.20

0.07

-8.33 to 0.39

>5 Years

-5.1

2.20

0.02*

-9.42 to -0.70

* Represents statistically significant finding
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9C. HEI-2015.
ANOVA
HEI
Sum of
Squares
Between Groups

df

Mean Square

672.560

2

336.280

Within Groups

35219.496

197

178.779

Total

35892.056

199

Mean Difference

Std. Error

F

Sig.

1.881

p-value

.155

95% Confidence
Interval (CI)

<5 Years

1.61

2.39

0.50

-3.10 to 6.32

>5 Years

5.49

2.87

0.057

-0.16 to 11.15

Figures:
Figure 1. Structures of Estradiol vs. Bisphenol A
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Figure 2. NF-kB Canonical Pathway (Figure adapted from Park et al., 2016)

Figure 3. Epigenetic Modifications Causing an Increase to Cancer Risk (Figure adapted
from Bishop et al., 2015).
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4. Appendices
Logistic Regression on Cancer Presence Based on Dietary Components
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T-Test Looking at Cancer Prevalence Between Ethnic Groups (White & Non-White)
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48
One-Way ANOVA Looking at Difference in BPA, Fatty Acid, or Cancer Prevalence Between
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Multiple Regression Looking at BPA and Dietary Components to Explain Prevalence of Cancer
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51
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